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Abstract
Late-phase long term potentiation (L-LTP) is thought to be the cellular basis for long-term memory (LTM). While LTM as
well as L-LTP is known to depend on transcription and translation, it is unclear why brain-derived neurotrophic factor
(BDNF) could sustain L-LTP when protein synthesis is inhibited. The persistently active protein kinase f (PKMf) is the only
molecule implicated in perpetuating L-LTP maintenance. Here, in mouse acute brain slices, we show that inhibition of
PKMf reversed BDNF-dependent form of L-LTP. While BDNF did not alter the steady-state level of PKMf, BDNF together
with the L-LTP inducing theta-burst stimulation (TBS) increased PKMf level even without protein synthesis. Finally, in the
absence of de novo protein synthesis, BDNF maintained TBS-induced PKMf at a sufficient level. These results suggest that
BDNF sustains L-LTP through PKMf in a protein synthesis-independent manner, revealing an unexpected link between
BDNF and PKMf.
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Introduction
LTP in acute hippocampus slices has long been used as a model
to study the cellular mechanisms underlying learning and memory.
There are temporally distinct types of LTP: protein synthesis-
independent early phase LTP (E-LTP) and protein synthesis-
dependent late phase LTP (L-LTP) [1,2,3], paralleling the two
forms of memory – short-term and long-term memories [4]. While
numerous studies have been done on E-LTP, much less is known
about the mechanisms for L-LTP. The secreted trophic protein
BDNF and intracellular signaling molecule PKMf are the two
best-studied molecules; both are necessary and sufficient to
maintain L-LTP [5,6,7,8,9]. BDNF through its presynaptic or
postsynaptic TrkB receptor activates the downstream mitogen-
activated protein kinase (MAPK), phosphatidylinositol 3- kinase
(PI3K) and phospholipase C-c (PLC-c) pathways [10]. PKMf is
a brain-specific, atypical isoform of protein kinase C. It is per-
sistently active, due largely to the lack of regulatory domain and
therefore second-messenger-independent [11]. BDNF and PKMf
share several common characteristics in regulating hippocampal
L-LTP. First, either perfusion of BDNF or intracellular introduc-
tion of PKMf directly facilitates synaptic transmission by pro-
moting postsynaptic responses [9,12,13,14]. Second, inhibition of
either BDNF or PKMf abolishes L-LTP [5,15]. Third, BDNF and
PKMf could modulate the morphological changes of dendritic
spines [12,16]. However, the relationships between the two mole-
cules in regulating L-LTP remain unclear.
Substantial evidence suggests that the expression of BDNF gene
is controlled by neuronal activity [17]. In the hippocampus, the
BDNF mRNA levels in the CA1 region are rapidly increased in
response to the L-LTP inducing tetanic stimulation [18,19]. Weak
tetanic stimulation, which normally induces only E-LTP, could
induce L-LTP as long as the BDNF levels are elevated [5]. With
these results, one can hypothesize that strong tetani trigger the
expression of BDNF which in turn enhances the synthesis of
PKMf in the hippocampus, leading to L-LTP. However, appli-
cation of BDNF could rescue L-LTP deficits even when protein
synthesis is completely blocked [5]. These perplexing results raise
the possibility that BDNF may increase the PKMf level not by
enhancing its synthesis but by reducing degradation to achieve
LTP maintenance.
The present study attempts to reveal a mechanistic link between
BDNF and PKMf. We found that BDNF-related neuronal activi-
ties augmented PKMf expression but BDNF alone did not modu-
late steady-state PKMf protein level. Moreover, in the absence of
protein synthesis, BDNF sustained L-LTP by maintaining activity-
induced PKMf at a sufficient level. These results together suggest
that BDNF-dependent L-LTP is mediated by PKMf, and explain
how BDNF can maintain L-LTP even when protein synthesis is
completely blocked.
Results
PKMf mediates BDNF-dependent late phase LTP
Previous studies indicate that L-LTP can be further divided into
the BDNF-dependent form which can be induced by theta burst
stimulation (12 TBS) or a perfusion of cAMP analogs such as
forskolin, and the BDNF-independent form which is triggered by
PLoS ONE | www.plosone.org 1 June 2011 | Volume 6 | Issue 6 | e21568the classic 4 sets of tetanus (46tetani) [20]. PKMf is known to
mediate L-LTP induced by 4 tetani [21]. To determine whether
PKMf is also responsible for BDNF-dependent form of L-LTP, we
applied ZIP, a myristoylated PKMf-substrate peptide inhibitor
(5 mM), well after the BDNF-dependent L-LTP was expressed. In
12 TBS-induced L-LTP, ZIP applied 1 hour after stimulation suc-
cessfully reversed L-LTP (Fig. 1A, 1B, 9968% at 175–180 min,
p,0.01 compared with control). In contrast, a scrambled ZIP
peptide (5 mM) did not affect L-LTP maintenance (166613% at
175–180 min). Forskolin-induced L-LTP was induced by a 15-min
perfusion of a combined forskolin (50 mM) and the phosphodies-
terase inhibitor IBMX (30 mM). ZIP was applied 80 min after
LTP induction when a stable L-LTP was fully established. Again,
ZIP abolished L-LTP (Fig. 1C, 1D, 10366% for ZIP, 184618%
for Scrambled ZIP, at 175–180 min, p,0.001). These results
suggest that PKMf is required for the maintenance of BDNF-
dependent
L-LTP.
Steady-State PKMf level is not maintained by BDNF
To investigate whether and how BDNF regulates PKMf ex-
pression, we tested steady-state PKMf expression in wild-type
(WT) and homozygous BDNF knockout (KO) mice. At postnatal
day 18 (P18), brain tissues were dissected and subjected to Western
Figure 1. BDNF-dependent late phase LTP is mediated by PKMf. (A, B) 12 TBS-induced L-LTP was reversed by PKMf inhibitor ZIP. Field EPSP
(fEPSP) was evoked in CA1 stratum radiatum by stimulating Schaffer Collateral in adult C57BL/6 mice. (A) After a stable baseline was obtained, 12 TBS
was conducted. LTP was sustained at least for 3 hours. ZIP (5 mM) or scrambled ZIP peptide (5 mM) was applied at 1 hour after stimulation. (B)
Quantification of the initial slope value from the last 5 minutes recording. (C, D) Forskolin-induced L-LTP was abolished by PKMf inhibitor ZIP. The
experiments were done identically as in (A), except that L-LTP was induced by a transient perfusion of forskolin (50 mM) and IBMX (30 mM) for
15 minutes. ZIP or scrambled ZIP was applied at 80 minutes after chemical induction when stable L-LTP was fully established. Numbers of slices and
mice used in each condition are indicated at the top of each plot. In this and all other figures, data are presented as mean 6 s.e.m. * p,0.05,
** p,0.01,*** p,0.001, Student’s t-Test.
doi:10.1371/journal.pone.0021568.g001
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endogenous PKMf expression between WT and KO mice in the
cortex and hippocampus, respectively (Fig. 2A, Cortex, p=0.79;
Hippocampus, p=0.52).
A number of studies have demonstrated that BDNF promotes
gene transcription and translation [22]. We next investigated
whether exogenous BDNF treatment affected PKMf protein level
in primary neuron culture. Embryonic neurons derived from WT,
heterozygous (Het) and KO mice were cultured for 7 days (DIV 7)
and then exposed to BDNF (100 ng/ml) or vehicle for 24 hours,
and total PKMf protein level was measured by Western blot.
Addition of BDNF did not cause any significant change in the
levels of PKMf in WT or BDNF mutant genotypes (Fig. 2B, WT,
p=0.91; Het, p=0.44; KO, p=0.34). Thus, it appears that
without substantial enhancement of neuronal or synaptic activities,
BDNF does not alter the steady-state level of PKMf protein.
BDNF modulates activity-dependent PKMf levels to
sustain L-LTP in the absence of protein synthesis
We have previously shown that treatment with BDNF is
sufficient to rescue L-LTP impairment when protein synthesis is
completely blocked [5]. We attempted to examine whether BDNF
could modulate PKMf to sustain the L-LTP at this situation.
Consistent with the previous study, L-LTP was fully established by
Figure 2. Steady-State PKMf protein level is not regulated by BDNF. (A) PKMf protein level in cortex and hippocampus of BDNF KO and WT
littermates. At postnatal day 18, cortex or hippocampus from BDNF KO and WT littermates were dissected and subjected to Western blot.
Representative blots and quantification of data were shown. GAPDH was used as loading control. (n=5–8 independent experiments). (B) PKMf
expression in primary neuron cultures derived from different genotypes after BDNF treatment. DIV 7 cortical primary cultures of WT, Het or KO
genotype were separately treated with BDNF (100 ng/ml) or vehicle for 24 hours. For each experiment, BDNF treatment group was normalized
against vehicle treatment group. Representative blots are shown on top of the quantification of data. (n=5 independent experiments).
doi:10.1371/journal.pone.0021568.g002
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impairment by BDNF in the presence of anisomycin is PKMf-dependent. (A) Applications of various drugs were indicated by horizontal bars.
Anisomycin (40 mM) was used throughout the entire experiment. BDNF (200 ng/ml) was applied 3 minutes after 12TBS stimulation and successfully
rescued L-LTP impairment. ZIP was applied at 1 hour after stimulation and completely abolished L-LTP. (B) Quantification of the initial slope from the
last 5 minutes of recording. (C) PKMf protein level of hippocampal CA1 derived from WT mice at 1 hour and 3 hours after 12TBS stimulation. Tubulin
was used as loading control. The 12 TBS group was normalized against control group. The 12 TBS plus BDNF and anisomycin treatment groups were
normalized against that without BDNF treatment. Representative blots are shown on top of the quantification of data (3–5 slices per treatment, n=3
independent experiments).
doi:10.1371/journal.pone.0021568.g003
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anisomycin (40 mM). We next applied PKMf inhibitor ZIP at
1 hour after tetanus and found L-LTP was completely reversed
(Fig. 3A–3B, 9466% for ZIP, 160615% for Scrambled ZIP, at
175–180 min, p,0.001). These results raise the possibility that
BDNF regulates PKMf to ensure a sustained L-LTP through a
protein synthesis independent mechanism.
To further characterize how BDNF regulates PKMf,w ec o m -
pared PKMf level in the hippocampal slices at different time
points after 12 TBS. The 12 TBS group was normalized against
control condition in which slices were not stimulated. The 12
TBS plus BDNF and anisomycin treatment groups were nor-
malized against that without BDNF treatment. The PKMf
signals on the Western blot were normalized to that of b-tubulin
on the same lane. At the early stage of L-LTP (around 1 hour
after tetanus), synaptic activation induced a small but statistically
significant increase of PKMf level (Fig. 3C, 11665.8%, p,0.05).
This elevation of PKMf level was protein synthesis dependent.
Application of BDNF (200 ng/ml) together with 12TBS did not
further increase PKMf level. At the late stage of L-LTP (around
3 hour after tetanus), the BDNF-treated slices exhibited a much
higher level of PKMf compared with the one in the presence of
anisomycin (Fig. 3C, 161.6620.5%, p,0.05). Thus, BDNF
combined with strong tetanus could increase the steady-state level
of PKMf when protein synthesis is completely blocked. These
results suggest that in the absence of protein synthesis strong
tetanic stimulation together with BDNF could somehow elevate
PKMf protein level, which in turn is responsible for L-LTP
maintenance.
Discussion
Although L-LTP is known to be dependent on translation, it
has been puzzling why BDNF could rescue the L- LTP deficit in
the presence of the protein synthesis inhibitor anisomycin [5].
Considering that anisomycin may elicit unspecific stress-related
pathways [23], we previously also applied emetine (20 mM) to
block protein synthesis. A similar rescuing effect of BDNF was
observed in L-LTP impairment, validating the notion that BDNF
promotes L-LTP maintenance in the absence of protein synthesis
[5]. In the present study, we have revealed an unexpected role of
PKMf in mediating this BDNF-dependent form of L-LTP. In the
absence of protein synthesis, BDNF seems to sustain L-LTP by
means of maintaining a sufficient level of activity-induced PKMf.
These data provide a mechanistic link between BDNF and PKMf
and suggest their critical role in the maintenance of L-LTP despite
of protein synthesis inhibition.
Unlike the classic, tetanus-induced L-LTP, the cAMP or 12TBS
induced L-LTP requires an increase in local concentration of
dendritic proteins but not nucleus activity [24], and is dependent
on BDNF [20]. Similar to the classic L-LTP, however, we now
demonstrate that the BDNF-dependent L-LTP also requires
PKMf. Interestingly, in primed L-LTP through type I mGluRs
activation, neither suppression of BDNF nor PKMf alone could
reverse L-LTP. But a co-inhibition of BDNF and PKMf com-
pletely abolishes its maintenance [25]. These results could be
interpreted as PKMf acts either in parallel or synergistically with
BDNF. However, we provide several lines of evidence suggesting
that PKMf could be downstream of BDNF, at least in BDNF-
dependent L-LTP. First, application of the PKMf inhibitor ZIP
after cAMP or 12 TBS reverses the BDNF-dependent LTP.
Second, BDNF together with 12TBS increases hippocampal
PKMf level. Finally, in the presence of anisomycin, BDNF rescue
of L-LTP deficit could be reversed by ZIP.
In general, BDNF-TrkB signaling is crucial for activity-induced
new protein synthesis [22]. Moreover, synthesis of PKMf is a
common target of many signaling pathways in LTP induction,
including the major BDNF downstream pathways, such as PI3-
kinase, MAPK, mTOR, etc [26,27]. However, we did not detect a
difference of steady-state PKMf expression between WT and
BDNF KO mice. Further, application of BDNF to cultured WT
neurons did not increase PKMf protein level. We reasoned that
BDNF may need to work together with high frequency neuronal
activity to up-regulate PKMf through a protein synthesis inde-
pendent mechanism. Indeed, we found that BDNF together with
the L-LTP inducing 12TBS increases the PKMf protein level,
even in the presence of anisomycin.
How BDNF maintains PKMf level without protein synthesis?
One attractive hypothesis is that BDNF inhibits TBS-induced
degradation of PKMf through the ubiquitin-proteasome system
(UPS). A balance in protein synthesis and degradation has been
implicated in the maintenance of long term plasticity, structurally
and functionally [28]. When protein synthesis is inhibited, PKMf
level decreases primarily through UPS-mediated degradation.
Given that BDNF-TrkB signaling acts upstream of UPS coupling
neuronal activity with protein turnover [29], it is possible that
BDNF counters PKMf degradation to maintain L-LTP. Indeed,
without BDNF treatment, PKMf level keeps low under anisomy-
cin perfusion [30]. Moreover, there is a critical window for BDNF
to rescue L-LTP impairment — no later than 10 minutes after
tetanus [5]. An alternative hypothesis is that BDNF regulates
PKMf protein translocation to the stimulated synaptic site.
According to ‘‘synaptic tagging’’ theory, PKMf is suggested as a
plasticity-related protein (PRP) that not only potentiate synaptic
responses at strongly tetanized pathways, but also at weakly
stimulated pathways as long as synaptic tags are set [31]. BDNF
may facilitate PKMf translocation from cytoplasm to synaptic
sites. Specifically, when protein synthesis is inhibited, a local short-
age of newly synthesized PKMf may drive the need for PKMf
translocation and BDNF may facilitate this process. Regardless, it
is critical for BDNF to hold PKMf at a sufficient level within this
window before it is completely consumed by dynamic neuronal
activities.
Taken together, these results expand the range of BDNF
modulation of long term plasticity beyond a protein synthesis
dependent manner and provide a strong mechanistic link between
BDNF and PKMf in the maintenance of L- LTP.
Materials and Methods
Ethics Statement
All experiments were approved by the National Institutes of
Health (NIH) Animal Care and Use Committee and followed the
NIH Guidelines ‘‘Using Animals in Intramural Research’’. The
NICHD Animal Use Proposal Number is 07-020.
Animals
Homozygous BDNF knockout mice (KO), and wild type (WT)
littermates were derived from BDNF heterozygous breeding pairs
in C57BL/6 background as described [32].
Western Blotting
Brain tissues or primary neuron cultures were lysed in RIPA
buffer containing (in mM): 50 Tris-HCl (pH 7.4), 150 NaCl, 2
EDTA, 1% IGEPAL, 0.1% SDS, a cocktail of protease inhibitor
(Calbiochem, San Diego, CA) and phosphatase inhibitor (Calbio-
chem, San Diego, CA). Lysates were homogenized by sonication.
Supernatants were collected after centrifugation at 13,200 rpm for
BDNF Facilitates L-LTP Maintenance through PKMf
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DC protein assay (Bio-Rad, Hercules, CA). For Western blot
analysis, protein samples were mixed with LDS sample buffer
(Invitrogen, Carlsbad, CA) and separated by Bis-Tris 4–12% gel
(Invitrogen, Carlsbad, CA). Proteins were transferred to a PVDF
membrane by iBlot (Invitrogen, Carlsbad, CA). After blocking in
Tris buffer saline-1% non-fat dry milk for 1 hour, membranes
were probed with rabbit anti-PKMf (C-terminal, 1:500, kindly
provided by Dr. Sacktor Todd) overnight at 4uC. HRP-conjugated
secondary antibody (Pierce, Rockford, IL) was used for detec-
tion in a chemiluminescent system. Glyceraldehydes-3-phosphate
dehydrogenase (GAPDH) (1:10,000, Abcam, Cambridge, MA) or
Tubulin (1:5000, Abcam, Cambridge, MA) was used as loading
control in the same sample. Densitometric analysis was conducted
using ImageJ software (NIH, Bethesda, MD). All experiments were
repeated at least 3 times (n=3), using independent samples.
Primary Neuron Culture
Primary cortical neurons were cultured from embryos produced
by crossing BDNF heterozygous animals. Each fetus (E18) was
dissected carefully to prevent blood contamination. A tissue chunk
was pinched off for genotyping. Cortices from fetuses of the same
genotype were digested with trypsin, dissociated and plated
together. At DIV 7, vehicle or BDNF (100 ng/ml) was applied
to cultures for 24 hours.
Electrophysiological Recording
Animals (6–10-week old, in C57BL/6 background) were
anesthetized and decapitated. Brains were placed in ice-cold high
Mg
2+ artificial cerebrospinal fluid (ACSF) (in mM: 124 NaCl, 26.2
NaHCO3, 1 NaH2PO4, 4.4 KCl, 1.25 CaCl2, 2.6 MgSO4,1 0D -
Glucose) bubbled with 95% O2 and 5% CO2. Transverse
hippocampus slices (400 mm thick) were prepared with a vibrating
microtome (Leica, Germany). The slices were stored submerged in
recording ACSF (124 NaCl, 26.2 NaHCO3, 1 NaH2PO4, 4.4
KCl, 2.5 CaCl2, 1.3 MgSO4, 10 D-Glucose) for 30 minutes at
34uC and 30 minutes at room temperature. Recording was made
in a submersion chamber (30uC, flow rate around 2 ml/min)
perfused with recording ACSF.
Field excitatory postsynaptic potentials (fEPSP) were evoked in
CA1 stratum radiatum by stimulating Schaffer Collateral with a
bipolar tungsten electrode and recorded with ACSF-filled glass
pipettes using an Axoclamp-2B amplifier (Axon Instruments,
Sunnyvale, CA). Recordings with maximal fEPSP less than 1 mV
or with substantial changes in the fiber volley were rejected.
Baseline responses were set to ,40% of maximal response and
were recorded for 15 minutes. Late phase long-term potentiation
was induced by tetanic stimulation, which contains 12 bursts, each
with 4 pulses at 100 Hz and an inter-burst interval of 200 msec.
For pharmacologically induced long-term potentiation, forsko-
lin (50 mM, Sigma, St. Louis, MO) and IBMX (30 mM, Sigma, St.
Louis, MO) were applied in bath for 15 minutes and washed out
with recording ACSF. The myristoylated zeta-pseudosubstrate
peptide (ZIP, 5 mM, myr-SIYRRGARRWRKL-OH, Invitrogen,
Carlsbad, CA) and its corresponding scrambled control peptide
(5 mM, myr-RLYRKRIWRSAGR-OH, Invitrogen, Carlsbad, CA)
were dissolved in Dimethylsulfoxide (DMSO). ZIP and scrambled
ZIP were applied to the bath 1 hour after stimulation.
The initial slope of the fEPSP was measured as an index of
synaptic strength. Data was analyzed by Clampfit 9 (Molecular
Devices, Sunnyvale, CA) and presented as mean 6 s.e.m..
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